Decatur, GA, United States of America

Weiqiang Zhan

USPTO Granted Patents = 3 



Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Weiqiang Zhan: Innovator in CXCR4 Antagonist Research

Introduction

Weiqiang Zhan is a notable inventor based in Decatur, GA, who has made significant contributions to the field of medical research. He holds three patents that focus on the development of CXCR4 antagonists, which are crucial for treating various medical disorders.

Latest Patents

Zhan's latest patents include innovative compounds and pharmaceutical compositions that act as antagonists of the chemokine CXCR4 receptor. One of his inventions provides methods for using these compounds to treat proliferative conditions mediated by CXCR4 receptors. These compounds are designed to interfere with the binding of SDF1 to the receptor, making them particularly effective in treating hyperproliferative diseases by inhibiting metastasis. Another patent focuses on CXCR4 antagonists that include diazine and triazine structures, which are useful not only for treating hyperproliferative diseases but also for reducing the entry of HIV into cells without compromising the proliferation capacity of stem cells. These compounds may be beneficial for long-term treatment regimens.

Career Highlights

Weiqiang Zhan is affiliated with Emory University, where he continues to advance his research in the field of medical science. His work has garnered attention for its potential impact on treating serious medical conditions.

Collaborations

Zhan has collaborated with esteemed colleagues such as Dennis C. Liotta and James P. Snyder, contributing to the advancement of research in his field.

Conclusion

Weiqiang Zhan's innovative work in developing CXCR4 antagonists showcases his commitment to improving medical treatments. His contributions are paving the way for new therapeutic options in the fight against proliferative diseases and viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…